AptarGroup, Inc. (ATR)
NYSE: ATR · Real-Time Price · USD
142.61
-0.56 (-0.39%)
Nov 17, 2026, 10:38 AM EST - Market open

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Aptar Pharma Revenue
1.79B1.74B1.64B
Aptar Beauty Revenue
1.43B1.31B1.23B
Aptar Closures Revenue
770.95M730.26M714.01M
Revenue (Total)
3.99B3.78B3.58B

Adjusted EBITDA

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Aptar Pharma Adjusted EBITDA
607.86M607.65M568.37M
Aptar Beauty Adjusted EBITDA
160.75M158.77M159.91M
Aptar Closures Adjusted EBITDA
112.68M116.48M114.14M
Corporate & Other Adjusted EBITDA
-71.85M-67.79M-67.50M
Operating Income (Other)
-333.94M-314.06M-278.43M
Operating Income (Total)
475.50M501.04M496.50M

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Aptar Pharma Core Sales Growth
3.00%8.00%
Aptar Beauty Core Sales Growth
2.00%-3.00%
Aptar Closures Core Sales Growth
1.00%3.00%
Total Core Sales Growth
2.00%3.00%